Keyphrases
Positron Emission Tomography-computed Tomography (PET-CT)
100%
CT-based
100%
Response Evaluation
100%
Response Evaluation Criteria in Solid Tumors (RECIST)
100%
Peptide Receptor Radionuclide Therapy
100%
Response Prediction
100%
Somatostatin Receptor PET
100%
Progressive Disease
54%
RECIST 1.1
45%
Overall Survival
36%
Standardized Uptake Value
36%
Median Overall Survival
27%
Neuroendocrine Tumor
18%
Response Assessment
18%
Lesion Progression
18%
Tumor
9%
Normal Liver
9%
Univariate Analysis
9%
2-cycles
9%
SUVmax
9%
Tumor Response
9%
Lesion Size
9%
Result-oriented
9%
Worse Prognosis
9%
Tumor-like Lesions
9%
Tumor Patients
9%
Lutetium-177 (177Lu)
9%
Suitable Method
9%
Survival Median
9%
Hounsfield Units
9%
EORTC
9%
Treatment Cycle
9%
First Cycle
9%
Methods for Assessment
9%
Liver Parenchyma
9%
Target Lesion
9%
SUVmean
9%
Change in Size
9%
DOTATOC
9%
Combined Parameters
9%
177Lu-DOTATATE
9%
Ga-68
9%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Radioisotope
100%
Somatostatin Receptor
100%
Polyethylene Terephthalate
100%
Overall Survival
63%
Diseases
54%
Neoplasm
27%
Neuroendocrine Tumor
18%
Lutetium 177
18%
Immunology and Microbiology
Positron Emission Tomography-Computed Tomography
100%
Peptide Receptor
100%
Somatostatin
100%
Overall Survival
63%
Liver Parenchyma
9%
Veterinary Science and Veterinary Medicine
Somatostatin
100%
Neoplasm
100%
Positron Emission Tomography-Computed Tomography
100%
Neuroendocrine Tumor
66%
Agricultural and Biological Sciences
Polyethylene Terephthalate
100%
Somatostatin Receptor
100%
Peptide Receptors
100%
Transponder
18%
Neuroscience
Positron Emission Tomography-Computed Tomography
100%
Somatostatin Receptor
100%
Receptor
100%
Parenchyma
9%